BOULDER, CO / ACCESS Newswire / February 4, 2026 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, today reported its financial results for its 2026 fiscal third quarter. Encision's CEO Robert Fries commented, "The Company's revenue has continued to decline principally because of procedures that were performed by surgical robots that have replaced our surgical pro ...

Core Insights - Encision Inc. reported financial results for the second quarter of fiscal 2026, ending September 30, 2025, highlighting a total net revenue of $1.52 million [1] - The company experienced a quarterly net loss of $268 thousand, translating to a loss of $(0.02) per diluted share [1] Financial Performance - The quarterly product net revenue was $1.48 million, while service net revenue was $46 thousand, contributing to the total net revenue of $1.52 million [1] - The net loss for the quarter was $268 thousand, indicating challenges in achieving profitability [1]